![Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37]](https://cedclinic.com/wp-content/uploads/2026/07/ced-pexels-5021600-150x150.jpg "Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37] 24")
#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians need to recognize that adolescent cannabis use disorder substantially increases psychotic and bipolar disorder risk, warranting early screening and intervention in this population. This evidence supports counseling patients and families about developmentally-sensitive harms of cannabis use during critical brain maturation periods, particularly for those with psychiatric vulnerability or family history.
This longitudinal study demonstrates that adolescents diagnosed with cannabis use disorder face approximately double the risk of developing psychotic disorders and bipolar disorder in adulthood compared to peers without such diagnoses. The findings underscore the neurodevelopmental vulnerability of the adolescent brain to cannabis exposure, particularly during critical periods of prefrontal cortex maturation when psychotic and mood regulation systems are still consolidating. Clinicians should use these data to inform risk counseling during substance use screening and to maintain heightened clinical vigilance for emerging psychotic or bipolar symptoms in young patients with cannabis use histories. This evidence is particularly important given changing social perceptions of cannabis safety and increasing adolescent access in legalized jurisdictions. For practitioners, systematically assessing cannabis use in adolescent psychiatric evaluations and providing families with frank information about psychotic and bipolar risk may support early intervention and prevention efforts in this vulnerable population.
⚠️ Emerging evidence suggests that adolescent cannabis use disorder is associated with substantially elevated risks for later psychotic and bipolar spectrum disorders, which warrants clinical attention during developmental periods when brain maturation is ongoing. However, the relationship between cannabis exposure and psychotic illness remains complex, involving potential confounders such as genetic vulnerability, socioeconomic stressors, concurrent substance use, and reverse causality (early prodromal symptoms may drive cannabis use). Clinicians evaluating adolescents and young adults should incorporate detailed cannabis use history into psychiatric risk assessment, particularly for patients with family histories of psychotic or mood disorders, while recognizing that causality has not been definitively established and that many cannabis users do not develop these conditions. Given the developing adolescent brain’s particular susceptibility to substance effects, discussing these potential long-term psychiatric risks during preventive health visits and substance use screening may help inform shared decision-making with patients and families considering cannabis
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
